Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-23

Clinical Trial Update: Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated pomalidomide with high-dose dexamethasone and oral cyclophosphamide in multiple myeloma; results were posted in May 2017 f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • DEXAMETHASONE (Dexamethasone)
  • Pomalidomide (Pomalidomide)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-23